Stimulation of free radical formation by aminoglycoside antibiotics

Hearing Research
S H Sha, Jochen Schacht

Abstract

We have previously shown gentamicin to form a redox-active iron chelate. This study investigates whether other aminoglycosides can likewise stimulate the generation of reactive oxygen species (free radicals). Kanamycin, neomycin and streptomycin were compared to gentamicin in intact cells and in cell-free in vitro assays using luminescence detection with lucigenin or luminol. Neutrophils and Epstein-Barr virus-transformed lymphoblastoid cells served as cell models in which a respiratory burst of superoxide was induced by phorbol ester. The addition of millimolar amounts of any of the aminoglycosides increased the luminescence significantly. The drugs also increased the formation of free radicals in an enzymatic (hypoxanthine-xanthine oxidase) and a non-enzymatic (phenazine methosulfate-NADH) superoxide-generating system. Half-maximal stimulation was reached with (0.4 mM gentamicin, and there was an absolute requirement for an electron donor, arachidonic acid. In both intact cells and cell-free systems, gentamicin-enhanced luminosity was suppressed by iron chelators. These results demonstrate that different aminoglycoside antibiotics can stimulate the formation of free radicals in biological and in cell-free systems. Luminescenc...Continue Reading

References

Jan 1, 1979·Archives of Oto-rhino-laryngology·J Schacht
Nov 1, 1992·American Journal of Medical Genetics·R T PrezantN Fischel-Ghodsian
Apr 15, 1992·Biochemical Pharmacology·S A CrannJ Schacht
Dec 1, 1990·Biochemical Pharmacology·M Y Huang, J Schacht
Mar 12, 1987·Journal of Immunological Methods·H Gyllenhammar
Feb 1, 1988·The Journal of Clinical Investigation·P D Walker, S V Shah
Jul 1, 1986·Antimicrobial Agents and Chemotherapy·D DulonJ Schacht
Oct 1, 1987·The American Journal of Physiology·P D Walker, S V Shah
Mar 1, 1981·Hearing Research·M G Pierson, A R Møller
Mar 1, 1983·Hearing Research·G R BockP Moorjani
Sep 1, 1983·The Journal of Clinical Investigation·P A WardC Beauchamp
Nov 27, 1995·Biochemical Pharmacology·E M Priuska, J Schacht
Jan 1, 1997·Archives of Biochemistry and Biophysics·S I Liochev, I Fridovich
Feb 24, 1998·The Laryngoscope·B J ConlonD W Smith
Jul 17, 1998·Free Radical Biology & Medicine·B B SongJ Schacht
Jan 23, 1999·Free Radical Biology & Medicine·S H Sha, J Schacht

❮ Previous
Next ❯

Citations

Nov 8, 2003·Journal of the Association for Research in Otolaryngology : JARO·P S SteygerC F Dai
Feb 16, 2013·Apoptosis : an International Journal on Programmed Cell Death·Allison B CoffinEdwin W Rubel
Oct 3, 2002·Biochemical and Biophysical Research Communications·M C Becerra, I Albesa
Jul 6, 2002·European Journal of Pharmacology·Dorota WrześniokJerzy Palka
Feb 14, 2003·Toxicology and Applied Pharmacology·Sandra L McFaddenRichard J Salvi
Dec 18, 2001·Hearing Research·C T TanS Y Lin-Shiau
Jul 18, 2002·Hearing Research·Murat Cem MimanErcument Olmez
Nov 16, 2002·Hearing Research·Sandra L McFaddenRichard J Salvi
Jan 9, 2008·Molecular Therapy : the Journal of the American Society of Gene Therapy·Yuhe LiuKeiya Ozawa
Jun 16, 2012·Proceedings of the National Academy of Sciences of the United States of America·Tanja MattErik C Böttger
Feb 11, 2009·Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association·Fabricia PetronilhoFelipe Dal-Pizzol
Mar 8, 2003·American Journal of Respiratory and Critical Care Medicine·Kelvin H-V TanAlan R Smyth
Jun 19, 2014·International Journal of Molecular Medicine·John Karijolich, Yi-Tao Yu
Jan 24, 2014·The Journal of Laryngology and Otology·V KahyaO Ozturan
Mar 5, 2014·Journal of the Association for Research in Otolaryngology : JARO·C G Le PrellJ M Miller
Nov 29, 2011·International Journal of Otolaryngology·M E HuthA G Cheng
Dec 29, 2007·Drug and Chemical Toxicology·Eloisa Nogueira MaudonnetMiguel Angelo Hyppolito
Aug 12, 2009·Experimental and Toxicologic Pathology : Official Journal of the Gesellschaft Für Toxikologische Pathologie·N OzakiU Deschl
Jun 29, 2004·Acta Oto-laryngologica. Supplementum·B SergiM Maurizi
Mar 12, 2016·Scientific Reports·Kari L GreenYehoash Raphael
Jul 24, 2010·British Journal of Pharmacology·Jian YaoMasanori Kitamura
Sep 29, 2006·Hearing Research·Kazuma SugaharaLisa L Cunningham
Oct 12, 2004·Otolaryngologic Clinics of North America·Avik Banerjee, Lorne S Parnes
Oct 18, 2011·Expert Opinion on Drug Metabolism & Toxicology·Joshua G YorgasonFederico Kalinec
Jul 15, 2015·Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society·Daniel J FoxKathleen C M Campbell
Mar 13, 2001·Pharmacological Research : the Official Journal of the Italian Pharmacological Society·S H LeeC S Lee
Feb 14, 2015·Cell and Tissue Research·David N Furness
Jul 11, 2014·HNO·A Liebau, S K Plontke
Oct 11, 2005·Drug Discovery Today·Leonard P Rybak, Craig A Whitworth
Feb 11, 2014·Neuroscience·G PolonyT Zelles
Feb 19, 2013·Toxicology in Vitro : an International Journal Published in Association with BIBRA·Dorota WrześniokEwa Buszman
Mar 1, 2006·Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society·P Ø JensenN Høiby

❮ Previous
Next ❯

Related Concepts

Related Feeds

Aminoglycosides

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.

Aminoglycosides (ASM)

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.